Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324057447> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4324057447 endingPage "722" @default.
- W4324057447 startingPage "719" @default.
- W4324057447 abstract "The development of immune checkpoint inhibitors such as programmed cell-death receptor 1 (PD-1) antagonists has rapidly advanced chemotherapy within the last several decades. PD-1 targeted immunotherapy drugs like pembrolizumab, ipilimumab, nivolumab, and durvalumab have known associations with several immune-mediated dermatological reactions. We report a case in which an elderly male experienced segmental vitiligo after use of durvalumab therapy for small cell lung cancer. Distinct from non-segmental vitiligo, segmental vitiligo presents in a unilateral blaschkoid distribution and typically does not cross the midline. To our knowledge, checkpoint inhibitor-induced segmental vitiligo has yet to be documented." @default.
- W4324057447 created "2023-03-14" @default.
- W4324057447 creator A5006440560 @default.
- W4324057447 creator A5018970364 @default.
- W4324057447 creator A5057968941 @default.
- W4324057447 creator A5070465399 @default.
- W4324057447 date "2023-03-13" @default.
- W4324057447 modified "2023-09-30" @default.
- W4324057447 title "Linear Depigmented Macules and Patches in an Elderly Man" @default.
- W4324057447 doi "https://doi.org/10.25251/skin.7.2.11" @default.
- W4324057447 hasPublicationYear "2023" @default.
- W4324057447 type Work @default.
- W4324057447 citedByCount "0" @default.
- W4324057447 crossrefType "journal-article" @default.
- W4324057447 hasAuthorship W4324057447A5006440560 @default.
- W4324057447 hasAuthorship W4324057447A5018970364 @default.
- W4324057447 hasAuthorship W4324057447A5057968941 @default.
- W4324057447 hasAuthorship W4324057447A5070465399 @default.
- W4324057447 hasBestOaLocation W43240574471 @default.
- W4324057447 hasConcept C121608353 @default.
- W4324057447 hasConcept C126322002 @default.
- W4324057447 hasConcept C143998085 @default.
- W4324057447 hasConcept C16005928 @default.
- W4324057447 hasConcept C2777701055 @default.
- W4324057447 hasConcept C2777742743 @default.
- W4324057447 hasConcept C2778650287 @default.
- W4324057447 hasConcept C2779980618 @default.
- W4324057447 hasConcept C2780030458 @default.
- W4324057447 hasConcept C2780057760 @default.
- W4324057447 hasConcept C2781433595 @default.
- W4324057447 hasConcept C71924100 @default.
- W4324057447 hasConceptScore W4324057447C121608353 @default.
- W4324057447 hasConceptScore W4324057447C126322002 @default.
- W4324057447 hasConceptScore W4324057447C143998085 @default.
- W4324057447 hasConceptScore W4324057447C16005928 @default.
- W4324057447 hasConceptScore W4324057447C2777701055 @default.
- W4324057447 hasConceptScore W4324057447C2777742743 @default.
- W4324057447 hasConceptScore W4324057447C2778650287 @default.
- W4324057447 hasConceptScore W4324057447C2779980618 @default.
- W4324057447 hasConceptScore W4324057447C2780030458 @default.
- W4324057447 hasConceptScore W4324057447C2780057760 @default.
- W4324057447 hasConceptScore W4324057447C2781433595 @default.
- W4324057447 hasConceptScore W4324057447C71924100 @default.
- W4324057447 hasIssue "2" @default.
- W4324057447 hasLocation W43240574471 @default.
- W4324057447 hasOpenAccess W4324057447 @default.
- W4324057447 hasPrimaryLocation W43240574471 @default.
- W4324057447 hasRelatedWork W1781719481 @default.
- W4324057447 hasRelatedWork W2285109017 @default.
- W4324057447 hasRelatedWork W2415761526 @default.
- W4324057447 hasRelatedWork W2518718160 @default.
- W4324057447 hasRelatedWork W2568840114 @default.
- W4324057447 hasRelatedWork W3000961096 @default.
- W4324057447 hasRelatedWork W3104083510 @default.
- W4324057447 hasRelatedWork W3119432592 @default.
- W4324057447 hasRelatedWork W3170189973 @default.
- W4324057447 hasRelatedWork W4324057447 @default.
- W4324057447 hasVolume "7" @default.
- W4324057447 isParatext "false" @default.
- W4324057447 isRetracted "false" @default.
- W4324057447 workType "article" @default.